Cargando…
Correction for: ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637814/ https://www.ncbi.nlm.nih.gov/pubmed/37906268 http://dx.doi.org/10.18632/aging.205255 |
| _version_ | 1785146542080917504 |
|---|---|
| author | Wang, Liang Lyu, Yinfeng Li, Yuqing Li, Kunping Wen, Hui Feng, Chenchen Li, Ning |
| author_facet | Wang, Liang Lyu, Yinfeng Li, Yuqing Li, Kunping Wen, Hui Feng, Chenchen Li, Ning |
| author_sort | Wang, Liang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10637814 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Impact Journals |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106378142023-11-15 Correction for: ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen Wang, Liang Lyu, Yinfeng Li, Yuqing Li, Kunping Wen, Hui Feng, Chenchen Li, Ning Aging (Albany NY) Correction Impact Journals 2023-10-30 /pmc/articles/PMC10637814/ /pubmed/37906268 http://dx.doi.org/10.18632/aging.205255 Text en Copyright: © 2023 Wang et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Wang, Liang Lyu, Yinfeng Li, Yuqing Li, Kunping Wen, Hui Feng, Chenchen Li, Ning Correction for: ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen |
| title | Correction for: ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen |
| title_full | Correction for: ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen |
| title_fullStr | Correction for: ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen |
| title_full_unstemmed | Correction for: ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen |
| title_short | Correction for: ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen |
| title_sort | correction for: asxl1 promotes adrenocortical carcinoma and is associated with chemoresistance to edp regimen |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637814/ https://www.ncbi.nlm.nih.gov/pubmed/37906268 http://dx.doi.org/10.18632/aging.205255 |
| work_keys_str_mv | AT wangliang correctionforasxl1promotesadrenocorticalcarcinomaandisassociatedwithchemoresistancetoedpregimen AT lyuyinfeng correctionforasxl1promotesadrenocorticalcarcinomaandisassociatedwithchemoresistancetoedpregimen AT liyuqing correctionforasxl1promotesadrenocorticalcarcinomaandisassociatedwithchemoresistancetoedpregimen AT likunping correctionforasxl1promotesadrenocorticalcarcinomaandisassociatedwithchemoresistancetoedpregimen AT wenhui correctionforasxl1promotesadrenocorticalcarcinomaandisassociatedwithchemoresistancetoedpregimen AT fengchenchen correctionforasxl1promotesadrenocorticalcarcinomaandisassociatedwithchemoresistancetoedpregimen AT lining correctionforasxl1promotesadrenocorticalcarcinomaandisassociatedwithchemoresistancetoedpregimen |